Fingerprint
Dive into the research topics of 'Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy
Christian Manegold, Alex Adjei, Federico Bussolino, Federico Cappuzzo, Lucio Crino, Rafal Dziadziuszko, David Ettinger, Dean Fennell, Keith Kerr, Thierry Le Chevalier, Natasha Leighl, Mauro Papotti, Luis Paz-Ares, Maurice Pérol, Solange Peters, Robert Pirker, Elisabeth Quoix, Martin Reck, Egbert Smit, Everett Vokes
Research output: Contribution to journal › Review article › peer-review
4
Scopus
citations